Skip to content
#protein folding Open access

Stable Constitutive BiP Expression Prolongs Late-Stage GLP-1–Fc Accumulation in CHO Cells

Aug 2026 · Bioengineering · Vol 13 · 0 citations · 31 references
Medicine

TL;DR

Stable constitutive expression of host-derived BiP was associated with prolonged late-stage GLP-1–Fc accumulation in the producer population examined, and these kinetics are compatible with a model in which the timing of ER chaperone supply influences the maintenance of productive output.

Abstract

Chinese hamster ovary (CHO) cells are the principal platform for manufacturing recombinant biopharmaceuticals, but sustained production can exceed the protein-folding capacity of the endoplasmic reticulum (ER). Binding immunoglobulin protein (BiP/GRP78), encoded by Hspa5, is a major ER chaperone that supports folding and modulates unfolded protein response (UPR) signaling, yet increasing BiP abundance has produced beneficial or inhibitory outcomes depending on the recombinant product. Here, we introduced an additional Chinese hamster Hspa5 coding sequence under the constitutive EEF1A1 promoter into a CHO line producing a dulaglutide analogue comprising a modified GLP-1 peptide fused to human IgG4 Fc and compared the resulting stable DUL-BiP population with an empty-vector DUL-Neo control. At constant 37 °C, the two populations showed similar viable cell density and viability trajectories, whereas DUL-BiP cells continued extracellular GLP-1–Fc accumulation for approximately two days after accumulation in DUL-Neo cells had slowed and reached a 40% higher final titer in this experiment. Two independent temperature-shift experiments showed the same direction of the final-titer difference, although the increases were smaller and were accompanied by reduced peak viable cell density. Semi-quantitative immunoblot analysis of samples from the constant-temperature experiment showed a comparatively stable total BiP signal in DUL-BiP cells and a pronounced late increase in DUL-Neo cells, together with temporal changes in cleaved ATF6, eIF2α phosphorylation, and CHOP in both populations. Intracellular GLP-1–Fc did not progressively accumulate. Because the immunoblot time courses were derived from one biological fed-batch experiment, they are interpreted descriptively rather than as independent quantitative biological replicates. Stable constitutive expression of host-derived BiP was therefore associated with prolonged late-stage GLP-1–Fc accumulation in the producer population examined. These kinetics are compatible with a model in which the timing of ER chaperone supply influences the maintenance of productive output, while the underlying mechanism and generality to other producer populations or recombinant products remain to be established.

Read PDF

Similar papers

Open access Aug 2026

Enhancing TGF-β1 production in CHO cells via MS-275 treatment, Bax/Bak knockout, and PACEsol overexpression

Efficient production of recombinant human transforming growth factor-β1 (rhTGF-β1) in Chinese hamster ovary (CHO) cells is limited by low yields and inefficient precursor processing. Here, we developed an integrated strategy combining chemical and genetic engineering. Screening of additives revealed that the histon...

Kyungsoo Kim, Kyoung Eun Baek, G. Lee · 0 citations
Open access Oct 2026

Next-Generation Glutamine Synthetase Expression Vector for Therapeutic Protein Manufacturing Using CHO Cells.

The glutamine synthetase expression system is widely used for therapeutic protein biomanufacturing in Chinese hamster ovary (CHO) cells. Here, we present the design of an enhanced glutamine synthetase vector for generating CHOK1SV GS-KO stable pools that produce recombinant proteins at multigram-per-liter levels. We fi...

Yusuf B. Johari, Sophie J. Wensley, Malak A. Ammar et al. · 0 citations
Open access Sep 2026

SEC-seq reveals translation-focused metabolic strategies for high IgG productivity in clonal CHO cells.

Chinese hamster ovary (CHO) cells are the dominant host for therapeutic protein production, yet intra- and inter-clonal heterogeneity in manufacturing phenotypes, and the underlying metabolic and secretory circuitry, remain poorly defined at single-cell resolution. Using secretion encoded single-cell sequencing (SEC-se...

Jasmine Tat, Fides D. Lay, Jennitte L. Stevens et al. · 0 citations
Open access Aug 2026

Designing an optimized strategy for extracellular expression of recombinant human TNF-α in Escherichia coli

Extracellular protein expression in Escherichia coli is an elegant solution that addresses the complex issue of protein misfolding while simultaneously simplifying downstream processing steps. Human TNF-α was chosen as the target protein for export since it is a therapeutically important cytokine. Different genomic kno...

Akanksha, Sounak Dasgupta, Priyanka Jain et al. · 0 citations
Sep 2026

Transient Expression of an IL-1Ra−Fc Fusion Cytokine in Tobacco Species for Improved Anti-inflammatory Therapeutic Potential

The interleukin-1 receptor antagonist (IL-1Ra) is a key anti-inflammatory cytokine that inhibits interleukin-1 signaling by competitively binding to IL-1 receptors. However, recombinant IL-1Ra, currently produced in Escherichia coli, exhibits limited pharmacokinetics and requires frequent administration due to its sh...

Anith Kumar Rajendran, Vaishnavi Ashokkumar, T. Krishnaraj et al. · 0 citations

Related blog posts

Google DeepMind Blog Sep 30, 2026

Introducing SynthID Bio

Proof of concept for watermarking AI-generated proteins while preserving biological function.

MIT News · Artificial Intelligence Aug 27, 2026

Looking beyond natural sequences

A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.